Nav: Home

Nipping flu pandemics in the bud

May 10, 2017

The threat of a major flu pandemic is a perennial concern. Now scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu. They report their new device in ACS' journal Analytical Chemistry.

The gold standard of flu diagnostics involves expensive techniques, laboratory facilities, trained personnel and, most importantly, time. However, patients and doctors often don't have time on their side because some strains, such as H5N1, can cause severe illness and even death. And even common strains can be deadly in the elderly and small children. Existing rapid diagnostic tests can help with diagnoses, but these tests require multiple processing steps that still need to be performed with lab equipment in specialized facilities. So Paul Yager and colleagues set out to create a simpler, low-cost device that can be used during an office or hospital visit without expensive instruments.

The researchers incorporated multiple steps of influenza detection -- viral lysis, target protein capture, labeling, rinsing and an enzyme-driven color change -- into one device. A user has to swab the inside of a patient's nose, then insert the swab into the device and twirl it for 10 seconds to release the virus. The device takes care of the rest. After about 35 minutes, it produces a visual readout that can be seen with the naked eye or captured with a smartphone camera. The researchers trained staff at a children's hospital to use the device, and they tested it on 25 patients during a flu outbreak. The device detected influenza A, one of the primary causes of moderate to severe flu epidemics, with 70 percent accuracy. The materials and reagents for one of these single-use devices cost less than $6.
The authors acknowledge funding from the National Institutes of Health.

The abstract that accompanies this study is available here.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact

Follow us on Twitter | Facebook

American Chemical Society

Related Flu Articles:

Yarraman flu or horse flu? Words and graphics influence willingness to vaccinate
'Yarraman flu is a virus quickly infecting the US...' The mock announcement was enough to make readers worry.
Ontarians still skeptical of flu shot
Half of all people who avoid the flu shot do so because they question its importance and effectiveness, a new study from the University of Waterloo reports.
Nipping flu pandemics in the bud
The threat of a major flu pandemic is a perennial concern.
Killing flu viruses with help from a frog
Frog mucus is loaded with molecules that kill bacteria and viruses, and researchers are beginning to investigate it as a potential source for new anti-microbial drugs.
Asthmatics less able to fight off flu
People with asthma are likely to have worse symptoms when they get the flu because they have weaker immune systems, new Southampton research has shown.
In a bad flu season, high-dose flu vaccine appeared better at preventing deaths in seniors
Older adults are at high risk for serious complications from flu and account for a majority of flu-related deaths and hospitalizations.
'Who needs a flu shot? -- not me'
What impact do public health messages actually have on us?
Flu nasal spray provides similar protection against influenza as flu shot: Study
For the study, the research team conducted a three-year trial in a Hutterite colony, where people live communally and are relatively isolated from cities and towns, to determine whether vaccinating children and adolescents with the flu nasal spray provided better direct and community protection than the standard flu shot.
New findings on flu nasal spray
A study conducted in the Hutterite community found that immunizing children with the live attenuated influenza vaccine, the kind found in the flu nasal spray, did not provide better direct or community protection against influenza than the inactivated influenza vaccine, or standard flu shot.
Using 'big data' to fight flu
Thanks to 'big data', researchers have identified new molecules that are instrumental in the replication of the flu virus.

Related Flu Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...